Cue Biopharma Inc

NASDAQ:CUE   11:50:23 AM EDT
3.74
+0.16 (+4.47%)
Earnings Announcements

Cue Biopharma Reports First Quarter 2022 Financial Results

Published: 05/10/2022 21:38 GMT
Cue Biopharma Inc (CUE) - Cue Biopharma Reports First Quarter 2022 Financial Results.
Cue Biopharma - Reported Collaboration Revenue of About $1.0 Million and $1.6 Million for Three Months Ended March 31, 2022 and 2021, Respectively.
Cue Biopharma Inc Qtrly Net Loss per Common Share - Basic and Diluted$0.44.
Revenue is expected to be $1.59 Million
Adjusted EPS is expected to be -$0.41

Next Quarter Revenue Guidance is expected to be $0.97 Million
Next Quarter EPS Guidance is expected to be -$0.44

More details on our Analysts Page.